CASE STUDY: PHARMY II AND ETHYPHARM
In April 2019 Ethypharm Group announced a definitive agreement to acquire Pharmy II Laboratory.
To reinforce its commitment to pain management, Ethypharm completed the acquisition of Pharmy II, a well stablished laboratory founded in France in 1982.
Pharmy II laboratory specialises in the treatment of pain, particularly mechanical musculo-articular pain and provides healthcare professionals (rheumatologists, mesotherapists, sports physicians), as well as their patients, with a range of solutions designed to be injected locally, using the mesotherapy technique.
“By entering into a new “specialised” market, Ethypharm is strengthening its commitment to pain management and its support to healthcare professionals”.
Bertrand Deluard, Ethypharm Group CEO
Read the press release here